Cargando…
Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel
Cardiosphere-derived cells (CDCs) are under clinical development and are currently being tested in a clinical trial enrolling patients who have undergone a myocardial infarction. CDCs are presently administered via infusion into the infarct-related artery and have been shown in early clinical trials...
Autores principales: | Smith, Rachel Ruckdeschel, Marbán, Eduardo, Marbán, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732325/ https://www.ncbi.nlm.nih.gov/pubmed/23538511 http://dx.doi.org/10.4161/biom.24490 |
Ejemplares similares
-
Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction
por: Shen, Deliang, et al.
Publicado: (2012) -
Angiogenesis, Cardiomyocyte Proliferation and Anti-Fibrotic Effects Underlie Structural Preservation Post-Infarction by Intramyocardially-Injected Cardiospheres
por: Tseliou, Eleni, et al.
Publicado: (2014) -
Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial
por: Ostovaneh, Mohammad R, et al.
Publicado: (2021) -
Diffusion Tensor Cardiac Magnetic Resonance Reveals Exosomes From Cardiosphere-Derived Cells Preserve Myocardial Fiber Architecture After Myocardial Infarction
por: Nguyen, Christopher T., et al.
Publicado: (2018) -
Relative Roles of CD90 and c‐Kit to the Regenerative Efficacy of Cardiosphere‐Derived Cells in Humans and in a Mouse Model of Myocardial Infarction
por: Cheng, Ke, et al.
Publicado: (2014)